Dengue type 4 in Rio de Janeiro, Brazil: case characterization following its introduction in an endemic region

• Published in: BMC infectious diseases Vol. 17; no. 1; p. 410
• Main Authors: Heringer, Manoela, Souza, Thiara Manuele A, Lima, Monique da Rocha Q, Nunes, Priscila Conrado G, Faria, Nieli Rodrigues da C, de Bruycker-Nogueira, Fernanda, Chouin-Carneiro, Thaís, Nogueira, Rita Maria R, Dos Santos, Flavia Barreto
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 09.06.2017; BioMed Central; BMC
• Subjects: Adolescent; Antigen-antibody complexes; Antigenemia; Antigens; Brazil; Brazil - epidemiology; Child; Children; Coinfection - epidemiology; Coinfection - virology; Dengue; Dengue - epidemiology; Dengue - etiology; Dengue fever; Dengue Virus - classification; Dengue Virus - genetics; Dengue Virus - pathogenicity; Dengue virus type 4; Diagnosis; Disease; Disease Outbreaks; Distribution; Endemic; Epidemics; Epidemiology; Evaluation; Female; Genotype; Genotype & phenotype; Genotypes; Genotyping; Glycoproteins - immunology; Humans; Immunoglobulin M; Immunoglobulins; Infections; Infectious diseases; Laboratorial diagnosis; Laboratories; Male; Outbreaks; Phylogeny; Polymerase chain reaction; Populations; Public health; Rio de Janeiro; Sentinel health events; Serogroup; Surveillance; Tropical diseases; Vector-borne diseases; Venezuela; Viral diseases; Viral Nonstructural Proteins - immunology; Viremia; Viremia - epidemiology; Viruses; Brazil; Rio de Janeiro Brazil; Malaysia; Thailand; Roraima; Laboratorial diagnosis; Brazil; Dengue virus type 4; Rio de Janeiro; Phylogeny; Endemic
• ISSN: 1471-2334; 1471-2334
• DOI: 10.1186/s12879-017-2488-4

Due to the populations' susceptibility, DENV-4 introduction in 2010 led to the occurrence of explosive epidemics in the following years in Brazil. In 2011, DENV-4 was identified in Rio de Janeiro (RJ) and it was prevalent in 2012 and 2013. Here, we aimed to characterize clinical, epidemiological and laboratorial aspects of DENV-4 cases after this serotype introduction in an endemic scenario. Dengue suspected cases (n = 3727) were received and analyzed from January 2011 to December 2013, during outbreaks occurred in RJ, Brazil. Samples were submitted to virological, serological and molecular methods for case confirmation. DENV-4 cases (n = 705) were characterized according to the type of infection, disease severity and, viremia levels and NS1 antigenemia were accessed. Representative strains were partial sequenced for genotyping. DENV-4 was identified in 44.2% (705/1593) of dengue positive cases, virus isolated in 48.7% of the cases. Anti-DENV IgM was detected in 39.4% of the cases, however an increased detection was observed in cases with ≥4 days of symptoms (57.0%). NS1 antigen was identified in 41.5% of DENV-4 cases however, after immune complexes dissociation, the detection significantly increased (87.6%). Females were more affected than males, so did children aged 11-15 years old. Primary cases were more frequently observed than secondary ones and most of them were classified as dengue. No differences on NS1 antigenemia and viraemia within the groups were observed. Despite the higher frequency of severe disease on individuals >65 years old, no differences were observed among the groups and type of infection. However, DENV-4 fatal cases were more frequent on secondary infections (57.1%). DENV-4 Genotype II was identified with a probable origin from Venezuela and Colombia. It has been shown that laboratorial diagnosis is still a reliable tool for the disease surveillance, detecting and confirming emerging epidemics. Despite the occurrence of secondary infections, most DENV-4 cases presented a mild disease. As RJ is endemic for dengue, high rates of secondary infections would be expected. Despite the existence of two genotypes, only Genotype II was identified in our study.